| HOME >> MEDICINE >> TECHNOLOGY |
Biennial price cuts 94
Generic pricing and substitution 96
Innovative drug pricing 97
Future trends in Japanese pricing and reimbursement 98
Most likely scenario 100
Best case scenario 101
Worst case scenario 101
High growth emerging pharmaceutical markets 102
Pricing and reimbursement in Brazil 104
Pricing and reimbursement in Russia 104
Pricing and reimbursement in India 105
Pricing and reimbursement in China 105
Chapter 5 Global pricing and market access strategies 108
Summary 108
Introduction 109
Local optimization 109
Price differentials 109
Market access differentials 111
Global coordination 113
Launch sequence 113
Price differentials 115
Balancing local optimization and global coordination 119
Chapter 6 Pricing and market access planning 122
Summary 122
Introduction 123
Pricing research and modeling 123
Research methodology 123
Pricing models 126
Pharmacoeconomic models 131
Pricing across the lifecycle 136
Pricing in early stage R&D 137
Pricing in late stage R&D 137
Pricing for lifecycle management 138
Pricing for pharmacoeconomic planning 138
List of Figures
Figure 1.1: Trends in healthcare spend as a proportion of GDP, 1990-2007 21
Figure 1.2: Pharmaceutical expenditure as a share of total healthcare expenditure, 1990-2007 22
Figure 1.3: R&D productivity levels, 1999-2008 25
Figure 1.4: The rising cost of new drug development, 1975-2006 27
Figure 1.5: Impact of US patent expiries for leading drugs, 2008-2013 28
Figure 1.6: Generics market share by sales value, 2003-2007 29
Figure 1.7: Quarterly GDP growth, Q4 2007 – Q2 2009 31
Figure 2.8: Projections of total Medicare Part D spending, FY2007-2016 50
Figure
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |